Market News (Page 46) - TendieTensor

Market News Page 46 of 158 • 3,931 articles

Rubis: SECTEUR DES CARBURANTS EN CORSE : RUBIS REAGIT A LA DECISION DE L’AUTORITE DE LA CONCURRENCE

GlobeNewswire Inc. • Na

Rubis: SECTEUR DES CARBURANTS EN CORSE : RUBIS REAGIT A LA DECISION DE L’AUTORITE DE LA CONCURRENCE

11/17/2025 12:59 PM • Rubis was fined €64,670,000 by the Competition Authority for an alleged anticompetitive agreement in fuel supply, storage, and distribution in Corsica between 2016-2022. The company denies the allegations and maintains its commitment to competitive market practices.

SOLV - Mentioned as a spun-off healthcare business from 3M, with no specific performance details provided in the article
RBSFY - Received significant financial penalty of €64.67 million and publicly disputed the Authority's decision, indicating serious legal and reputational challenges

#antitrust #competition #fuel #Corsica #sanctions

Rubis: FUEL SECTOR IN CORSICA: RUBIS RESPONDS TO THE DECISION OF THE FRENCH COMPETITION AUTHORITY (AUTORITÉ DE LA CONCURRENCE)

GlobeNewswire Inc. • Rubis

Rubis: FUEL SECTOR IN CORSICA: RUBIS RESPONDS TO THE DECISION OF THE FRENCH COMPETITION AUTHORITY (AUTORITÉ DE LA CONCURRENCE)

11/17/2025 12:59 PM • Rubis was fined €64,670,000 by the French Competition Authority for alleged anti-competitive practices in fuel supply, storage, and distribution in Corsica between 2016 and 2022. The company denies the allegations and plans to appeal the decision.

RBSFY - Received significant financial penalties (€64,670,000) and faces allegations of anti-competitive practices, which could damage company reputation and potentially impact future business operations

#competition authority #fuel sector #Corsica #anti-competitive practices #sanctions

Alphabet Rallies To Record Highs, Bitcoin Falters At $94,000: What's Moving Markets Monday?

Benzinga • Piero Cingari

Alphabet Rallies To Record Highs, Bitcoin Falters At $94,000: What's Moving Markets Monday?

11/17/2025 12:40 PM • Wall Street started the week cautiously with mixed market performance. Alphabet surged to a record high after Berkshire Hathaway's significant investment, while tech stocks experienced volatility and Bitcoin continued its recent decline.

GOOG - Jumped nearly 5% to a record high after Berkshire Hathaway disclosed a $4.93 billion stake

#tech stocks #market performance #cryptocurrency #earnings #indices

WD-40 Company: Insider Buying Points to Deep Value as Shares Hit Multi-Year Lows

Investing.com • Thomas Hughes

WD-40 Company: Insider Buying Points to Deep Value as Shares Hit Multi-Year Lows

11/17/2025 12:38 PM • WD-40 Company shows potential value as insider buying signals confidence, with stock trading near multi-year lows. The company demonstrates solid financial performance, including revenue growth, margin improvements, and strong institutional support.

RIVN - Briefly mentioned in related articles, no substantive analysis provided in the main article text
WDFC - Multiple positive indicators including insider purchases, strong institutional ownership (91%), improving margins, moderate revenue growth, reduced debt, increased equity, and analyst price target suggesting 50% potential stock price gain

#insider buying #value stock #capital returns #margin improvement #institutional ownership

GlobeNewswire Inc. • Eramet Sa

Eramet : Rachat d'actions propres

11/17/2025 12:00 PM • Eramet announced the purchase of 16,500 of its own shares, primarily for potential future free share allocations to employees and management, with transactions occurring between 10-14 November 2025.

BROS - Rapidly expanding coffee chain with profitable operations and significant growth potential, increasing locations by 14% year-over-year
ERMAY - The share repurchase is a standard corporate financial practice for employee compensation and does not indicate significant positive or negative market signals. The transaction appears routine and strategic.

#share buyback #stock #employee compensation #corporate finance

GlobeNewswire Inc. • Eramet

Eramet: Purchase of own shares

11/17/2025 12:00 PM • Eramet announced the purchase of 16,500 of its own shares related to bonus share allocations for employees and corporate officers, with transactions occurring between November 10-14, 2025.

ERMAY - Share buyback is a routine financial activity indicating stable corporate management, with no significant positive or negative implications. The purchase is specifically for employee bonus share allocations, suggesting standard corporate governance practices.

#share buyback #bonus shares #corporate finance

Divisadero Street Opens New $56 Million Stride Position: Is the Stock a Buy?

The Motley Fool • Josh Kohn-Lindquist

Divisadero Street Opens New $56 Million Stride Position: Is the Stock a Buy?

11/17/2025 11:32 AM • Divisadero Street Capital Management acquired a new $55.85 million position in Stride, representing 2.44% of its assets. Despite a recent significant stock drop due to platform upgrade issues, the author sees potential opportunity in the online education company trading at a low earnings multiple.

RIVN - High-risk electric vehicle manufacturer with potential partnerships and future mass-market vehicle plans, but currently unprofitable and stock significantly down from historical highs
LRN - Mixed performance with earnings beat but significant enrollment loss (10,000-15,000 new enrollments) due to platform upgrade issues. Trading at low earnings multiple suggests potential value, but near-term challenges exist.

#online education #investment #platform upgrade #enrollment #technology services

Why Is Everyone Excited About AMD Stock?

The Motley Fool • Parkev Tatevosian, Cfa

Why Is Everyone Excited About AMD Stock?

11/17/2025 11:32 AM • AMD is gaining market share in the data center industry, signing major deals with AI companies that are expected to boost sales and profits in the coming years.

AMD - The company is expanding its presence in the lucrative data center market, securing significant AI-related deals that suggest strong future growth potential

#AMD #AI #data center #market share #technology stocks

Sustainable Secondary Packaging Market Trends, Segments, Share and Companies 2025-35

GlobeNewswire Inc. • Towards Packaging

Sustainable Secondary Packaging Market Trends, Segments, Share and Companies 2025-35

11/17/2025 11:00 AM • The global sustainable secondary packaging market is projected to experience significant revenue growth by 2034, driven by increasing demand for eco-friendly packaging solutions, government regulations, and rising e-commerce needs. Asia Pacific currently leads the market, with Europe expected to see substantial expansion.

MONDY - Offers reusable, recyclable, and compostable paper-based solutions, aligning with market sustainability trends

#sustainable packaging #secondary packaging #eco-friendly #circular economy #recyclable materials

Cell Harvesting Market to Reach USD 20.08 Billion, Growing at a Strong 12.95% CAGR by 2034

GlobeNewswire Inc. • Towards Healthcare

Cell Harvesting Market to Reach USD 20.08 Billion, Growing at a Strong 12.95% CAGR by 2034

11/17/2025 11:00 AM • The global cell harvesting market is projected to grow from $5.94 billion in 2024 to $20.08 billion by 2034, with a 12.95% CAGR, driven by increasing demand for regenerative medicine, cell-based therapies, and technological advancements in cell research.

VOO - Historically strong performance with 12.8% annual returns, potential for significant long-term growth
TMO - Leading player in cell harvesting market with advanced technologies and strong market presence

#cell harvesting #regenerative medicine #stem cell research #biotechnology #cell therapy

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

11/17/2025 11:00 AM • The Schall Law Firm is pursuing a class action lawsuit against aTyr Pharma for allegedly making false and misleading statements about its Phase 3 trial of Efzofitimod, potentially concealing the drug's true capabilities.

TSLA - Part of Magnificent Seven with significant market representation
ATYR - The company is accused of making false statements about its drug trial, potentially misleading investors about Efzofitimod's capabilities, which could result in financial damages and legal consequences

#securities fraud #class action lawsuit #Efzofitimod #Phase 3 trial

The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia

Benzinga • Piero Cingari

The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia

11/17/2025 10:47 AM • Investors are shifting focus from AI infrastructure builders to companies using AI for productivity gains, with Goldman Sachs identifying potential beneficiaries across finance, consulting, software, and HR services sectors.

FFAIW - Positive business developments including strategic advisor appointment, increased B2B preorders, and growing investor interest from Vanguard
BAC - Identified as potential AI productivity beneficiary in banking sector with back-office automation potential

#AI #productivity #investment #earnings #automation

DoubleDown Interactive to Donate $10,000 to Meals on Wheels America®

GlobeNewswire Inc. • Doubledown Interactive Co., Ltd.

DoubleDown Interactive to Donate $10,000 to Meals on Wheels America®

11/17/2025 10:00 AM • DoubleDown Interactive announced a $10,000 donation to Meals on Wheels America to support senior hunger and isolation, with a play-to-enter giveaway event on November 20, 2025 to engage players in the charitable initiative.

AAPL - Underperformed market, up 77% in three years, perceived as lacking in AI development
DDI - Company demonstrates corporate social responsibility by donating to a charitable cause and raising awareness about senior hunger

#donation #charity #seniors #social gaming #community support

Gene Therapies for Cancer Treatment Market Projects USD 238.77 Billion at 39.94% CAGR by 2034

GlobeNewswire Inc. • Towards Healthcare

Gene Therapies for Cancer Treatment Market Projects USD 238.77 Billion at 39.94% CAGR by 2034

11/17/2025 10:00 AM • The global gene therapies for cancer treatment market is expected to grow from $8.28 billion in 2024 to $238.77 billion by 2034, with a 39.94% CAGR. North America currently dominates the market, with CAR-T cell therapy leading market share and significant innovations driving growth.

MSFT - Part of top-performing Magnificent Seven stocks with strong market presence
LEGN - Mentioned as a key player in an emerging and rapidly growing gene therapy market for cancer treatment

#gene therapy #cancer treatment #CAR-T cell therapy #market growth #oncology

Holiday Retail Sales to Hit $1 Trillion: Which Giant Will Win Black Friday 2025?

Investing.com • Nathan Reiff

Holiday Retail Sales to Hit $1 Trillion: Which Giant Will Win Black Friday 2025?

11/17/2025 09:49 AM • The National Retail Federation predicts over $1 trillion in U.S. retail sales for the 2025 winter holidays, with Amazon, Walmart, and Target positioned to benefit from increased holiday spending despite economic challenges.

AMZN - Part of top-performing Magnificent Seven stocks with significant market representation
AMZN - Strong e-commerce presence, lowest online prices, extensive product variety, successful Black Friday sales, and international market reach

#Black Friday #holiday sales #retail #e-commerce #consumer spending

Nu Holdings Stock Presses Higher—Breakout on Deck?

Investing.com • Chris Markoch

Nu Holdings Stock Presses Higher—Breakout on Deck?

11/17/2025 09:44 AM • Nu Holdings reported strong Q3 earnings with 54% higher EPS, 41% revenue growth, and 127 million active customers. The digital bank showed robust financial performance with high customer engagement and potential for stock price breakout.

META - Part of Magnificent Seven with significant market presence but no specific performance highlights
NU - Demonstrated strong financial metrics including 54% EPS growth, 41% revenue increase, 17% customer base expansion, 83% customer activity rate, and record 31% return on equity

#fintech #digital banking #earnings report #financial services #AI-first approach

S&P 500 Forward Earnings Defy Typical Drift With Persistent Upgrades

Investing.com • Brian Gilmartin

S&P 500 Forward Earnings Defy Typical Drift With Persistent Upgrades

11/17/2025 09:38 AM • The S&P 500 forward earnings estimates are showing unexpected positive momentum, with analysts continuing to upgrade earnings projections for 2025-2027, contrary to typical downward estimate drift. Large-cap tech and AI-related sectors remain strong, though potential market challenges may emerge in 2026.

GOOG - Part of Magnificent Seven with significant market representation
GOOG - Part of large-cap tech and communication services sector with continued AI momentum

#S&P 500 #earnings estimates #AI #forward guidance #market outlook

Quantum Computing (QUBT) Stock Surges On Q3 Earnings, Company To Unveil Neurawave Computer This Week

Benzinga • Adam Eckert

Quantum Computing (QUBT) Stock Surges On Q3 Earnings, Company To Unveil Neurawave Computer This Week

11/17/2025 09:30 AM • Quantum Computing Inc reported strong Q3 earnings, beating analyst estimates with 280% year-over-year revenue growth and plans to unveil its Neurawave photonics-based reservoir computing system at SuperCompute25.

GOOGL - Part of Magnificent Seven with significant market representation
QUBT - Strong Q3 financial performance with revenue beating estimates, significant cash reserves, strategic technology development, and plans to demonstrate new computing system

#quantum computing #earnings #Neurawave #Dirac-3 #photonics

Leverage Shares by Themes expands its single stock Leveraged ETF lineup with NU, NET, OKTA, TER, NEM, CMG, ABNB, SPOT and SBUX

GlobeNewswire Inc. • Paul Marino

Leverage Shares by Themes expands its single stock Leveraged ETF lineup with NU, NET, OKTA, TER, NEM, CMG, ABNB, SPOT and SBUX

11/17/2025 09:00 AM • Leverage Shares by Themes introduced nine new single stock leveraged ETFs targeting 200% daily exposure to companies across various sectors, expanding their total leveraged ETF count to 43.

KO - Over 60 years of dividend increases, industry-leading brand, global distribution, fair current valuation, and 3% dividend yield
NET - Included in AI infrastructure investment theme with growth potential

#ETF #leveraged investment #single stock #market exposure

Varonis Recognized as a Finalist for the 2025 Microsoft Partner of the Year Award in the Marketplace Category

GlobeNewswire Inc. • Varonis Systems, Inc.

Varonis Recognized as a Finalist for the 2025 Microsoft Partner of the Year Award in the Marketplace Category

11/17/2025 09:00 AM • Varonis Systems has been named a finalist in the Marketplace Category of the 2025 Microsoft Partner of the Year Awards, recognizing its innovative data security solutions built on Microsoft technology.

VRNS - Recognized as a finalist in prestigious Microsoft Partner Awards, highlighting successful collaboration and technological innovation

#data security #Microsoft partnership #cloud innovation #AI automation

Corrugated Boxes for Transit Packaging Market Size, Trends & Trade Analysis 2025-2035

GlobeNewswire Inc. • Towards Packaging

Corrugated Boxes for Transit Packaging Market Size, Trends & Trade Analysis 2025-2035

11/17/2025 09:00 AM • The global corrugated boxes for transit packaging market is projected to grow from $345.35 billion in 2026 to $511.79 billion by 2034, with a 5.04% CAGR. Asia Pacific leads the market, driven by e-commerce, manufacturing growth, and sustainability trends.

WMT - Largest US retailer, extensive store network, over five decades of dividend increases, adaptable to economic conditions
IP - Offers wide variety of fiber-based corrugated packaging products for shipping and e-commerce needs

#corrugated boxes #transit packaging #e-commerce #sustainability #packaging market

ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS

Benzinga • Prnewswire

ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS

11/17/2025 08:50 AM • Oramed Pharmaceuticals announced a Rights Plan to protect against hostile takeovers, distributing one common stock purchase right per outstanding share, with rights becoming exercisable if a person/group acquires 15% or more of outstanding stock.

O - 30-year dividend growth history, largest net lease REIT, diversified market exposure, and high 5.5% dividend yield
ORMP - The company is implementing a defensive strategy to protect shareholders by establishing a rights plan that ensures fair treatment in potential acquisition scenarios, without indicating immediate positive or negative business performance

#rights plan #dividend #stock purchase #takeover defense

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

GlobeNewswire Inc. • Lifemd, Inc.

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

11/17/2025 08:00 AM • LifeMD announced lower cash-pay pricing for Wegovy and Ozempic medications at $199 per month, supporting patients paying out of pocket through its Weight Management Program in collaboration with Novo Nordisk.

SHW - Industry-leading paint and coatings company, 46-year dividend growth, technology-resistant business model
LFMD - Expanding affordable medication access, strengthening pharmaceutical partnerships, and positioning itself strategically in the weight management healthcare market

#GLP-1 #weight management #virtual healthcare #medication pricing

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5

GlobeNewswire Inc. • Arcutis Biotherapeutics, Inc.

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5

11/17/2025 08:00 AM • Arcutis Biotherapeutics has submitted a supplemental New Drug Application to the FDA for ZORYVE cream 0.3%, seeking approval to treat plaque psoriasis in children ages 2 to 5. If approved by the June 29, 2026 target date, it would be the first topical PDE4 inhibitor for this age group.

ADP - Trusted enterprise HR solutions, 50-year dividend growth history, resilient business model in human resources management
ARQT - Company is expanding treatment options for children, demonstrating innovation in dermatological care and potential market expansion

#FDA #psoriasis #pediatric treatment #topical medication #PDE4 inhibitor

Algorhythm Holdings to Announce its Financial Results for the Third Quarter 2025

GlobeNewswire Inc. • Brendan Hopkins

Algorhythm Holdings to Announce its Financial Results for the Third Quarter 2025

11/17/2025 08:00 AM • Algorhythm Holdings will release its Q3 2025 earnings on November 19, 2025, with a conference call to discuss financial results and provide a business update.

MCD - Global franchise model, 49-year dividend growth streak, steady revenue from royalties and global expansion potential
RIME - Standard earnings release with no explicit positive or negative financial indicators, routine announcement of quarterly results

#earnings #AI technology #logistics #conference call #Q3 2025